Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Concord Biotech Limited Call Transcript 2025

May 26, 2025

61064_rns_2025-05-26_4a8745b9-d6f4-4a42-849a-96387995e27b.pdf

Call Transcript

Open in viewer

Opens in your device viewer

CONCORD BIOTECH LIMITED

B-1601-1602, B-wing Mondeal Heights, Iskcon Cross Road, S. G. Highway, Ahmedabad-380015, Gujarat. Phone : +91-79-68138700 Fax : +91-79-68138725 CIN No.: L24230GJ1984PLC007440 Email ID: [email protected]

--------------------------------------------------------------------------------------------------------------------------------------------

May 26, 2025

To
The Manager, Lis�ng Department
Na�onal Stock Exchange of India Ltd.
Plot No. C/1 G Block,
Bandra-Kurla Complex, Bandra (East),
Mumbai -400 051
Symbol: CONCORDBIO
To
General Manager, Lis�ng Department
BSE Limited
Phiroze Jeejabhoy Towers,
Dalal Street,
Mumbai – 400 001
ScripCode: 543960

Dear Sir/Ma’am,

Subject: Earnings Call Invite for the opera�onal and fnancial performance of the Company for the Fourth Quarter and year ended 31[st] March, 2025

Pursuant to Regula�on 30 of the SEBI (Lis�ng Obliga�ons and Disclosure Requirements) Regula�ons, 2015, as amended from �me to �me, read with Para A of Schedule III thereto, we wish to inform you that the Company has arranged Earnings Call with Investor/Analyst (Par�cipants) to discuss the Audited Standalone and Consolidated Financial Results of the Company for the Fourth quarter and year ended 31[st] March, 2025, scheduled on Friday, 30[th] May, 2025 at 04:00 P.M. IST. The Earnings Call invite is enclosed for your records.

The conference/Earning Call Invita�on is enclosed herewith.

Kindly take the same into your records and oblige.

Thanking you, Yours faithfully

For Concord Biotech Limited

Digitally signed by PRAKASH PRAKASH LALCHAND SAJNANI LALCHAND SAJNANI Date: 2025.05.26 15:49:06 +05'30' Prakash Sajnani Company Secretary and Compliance Officer M. No. F6242

Encl: As above

-----------------------------------------------------------------------------------------------------------------------------------------Regd. Office & Plant : 1482-1486, Trasad Road, Dholka, Dist. Ahmedabad-382225. (India) Phone : +91-2714-222604, 398200 Fax : +91-2714-222504 Website : www.concordbiotech.com

==> picture [74 x 62] intentionally omitted <==

==> picture [120 x 58] intentionally omitted <==

==> picture [192 x 47] intentionally omitted <==

Concord Biotech

Earnings Conference Call Friday, 30[th] May 2025 4:00 pm (IST)

IIFL is pleased to invite you to join a conference call with the management of Concord Biotech (CONCORDB IN) to discuss the company’s business strategy and outlook post the declaration of its Q4FY25 financial results.

Mr. Sudhir Vaid– Chairman & Managing Director
Management participants Mr. Ankur Vaid –Joint Managing Director and CEO
Mr. Lalit Sethi– Chief Financial Officer
Mr. Prakash Sajnani– AVP, Accounts & Finance
Date / Time 30thMay 2025 (Friday) – 4:00 pm IST
(HK/Singapore – 7:00 pm, UK – 12 noon, USA – 7:00 am ET)
Conference dial-in numbers
Pre-registration link Diamond Pass Registration
India
Primary Number +91 22 6280 1259 / +91 22 7115 8160
International Toll-free number
USA 1-866 746 2133
UK 0-808 101 1573
Singapore 800-101 2045
HongKong 800-964 448

For further information, please contact:

Naman Bagrecha | Tel: +91 22 4646 4718 | Email: [email protected] Rahul Jeewani | Tel: +91 22 4646 4673 | Email: [email protected] Vivek Pandey | Tel: +91 22 4646 4705 | Email: [email protected]

IIFL - 24th floor, One Lodha Place, Senapati Bapat Marg, Lower Parel (W), Mumbai 400 013, Tel: (91-22) 4646 4600, Fax: (91-22) 4646 4700